Facebook
Messenger
Twitter
LinkedIn
Email
Print
‘Live’ Virus Research Impacts Pandemic Insights
Share this:
To solve the challenges presented by COVID-19, it's important to look to the past. History shows that collaboration is the way forward when uncovering secrets of an emerging virus. It is vital for many reasons, a key one being safety. Only a few labs can safely handle a "live," meaning infectious, sample.
No one knows that better than Hideki Ebihara, Ph.D., a Mayo Clinic virologist who leads Mayo's Emerging Virus Program. As a researcher with worldwide connections and deep experience studying emerging diseases, Dr. Ebihara and his lab are vital to Mayo's COVID-19 research efforts.
From the lab to clinical trials, and from diagnostics to decontamination, Dr. Ebihara's lab is a lynchpin for SARS-CoV-2 research that improves care and fosters a safe working environment at Mayo Clinic.
Having this facility to support Mayo's research, medical practice and education activities means good ideas can move into patient care for use when they’re needed.
Read more about this crucial laboratory in the fight against COVID-19 and other pandemics in Discovery's Edge, Mayo Clinic's research magazine offering insight into the process and progress of medical science at the world's largest group medical practice.
Make a gift now to help transform the future of health care today.
Eds Note: Through expertise, innovation and a commitment to its patient-first values, Mayo Clinic plays a leading role in the worldwide pandemic response. Watch Mayo [...]
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within
From developing tests to detect the virus in a matter of months to testing patients for antibodies, Mayo Clinic Laboratories has been at [...]